{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T19:30:19Z","timestamp":1765913419743,"version":"3.48.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T00:00:00Z","timestamp":1755993600000},"content-version":"vor","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018628","name":"Scientific Research Foundation of Education Department of Anhui Province of China","doi-asserted-by":"publisher","award":["2024AH050701"],"award-info":[{"award-number":["2024AH050701"]}],"id":[{"id":"10.13039\/501100018628","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017668","name":"Anhui Provincial Key Research and Development Plan","doi-asserted-by":"publisher","award":["2022e07020002"],"award-info":[{"award-number":["2022e07020002"]}],"id":[{"id":"10.13039\/501100017668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012232","name":"National Key Clinical Specialty Discipline Construction Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012232","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.pnpbp.2025.111473","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T08:19:41Z","timestamp":1755505181000},"page":"111473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dual role of Interleukin-18 in linking metabolic and psychiatric symptoms: Insights from machine learning in schizophrenia"],"prefix":"10.1016","volume":"141","author":[{"given":"Yali","family":"Chai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingrong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junwei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoming","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianliang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loufeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peijun","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuizhen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pnpbp.2025.111473_bb0005","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.bbi.2010.11.011","article-title":"Constitutive and LPS-regulated expression of interleukin-18 receptor beta variants in the mouse brain","volume":"25","author":"Alboni","year":"2011","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111473_bb0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12974-024-03154-z","article-title":"Targeting the immunoproteasome in hypothalamic neurons as a novel therapeutic strategy for high-fat diet-induced obesity and metabolic dysregulation","volume":"21","author":"Albornoz","year":"2024","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111473_bb0015","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1590\/1516-4446-2020-0908","article-title":"Lowered serum cesium levels in schizophrenia: association with immune-inflammatory biomarkers and cognitive impairments","volume":"43","author":"Almulla","year":"2021","journal-title":"Rev. Bras. Psiquiatr."},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111473_bb0020","article-title":"Metabolic syndrome and its associated factors among patients with schizophrenia treated with second-generation antipsychotics at amanuel mental specialized hospital, Ethiopia","volume":"16","author":"Beyene","year":"2024","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111473_bb0025","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3390\/ph14050446","article-title":"Cytokine level changes in schizophrenia patients with and without metabolic syndrome treated with atypical antipsychotics","volume":"14","author":"Boiko","year":"2021","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111473_bb0030","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/s41380-021-01339-z","article-title":"Multi-omics of human plasma reveals molecular features of dysregulated inflammation and accelerated aging in schizophrenia","volume":"27","author":"Campeau","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111473_bb0035","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/schbul\/sby058","article-title":"Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016","volume":"44","author":"Charlson","year":"2018","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111473_bb0040","article-title":"The burden of depression, anxiety and schizophrenia among the older population in ageing and aged countries: an analysis of the global burden of disease study 2019","volume":"37","author":"Cheng","year":"2024","journal-title":"Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111473_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107413","article-title":"Relevance of the antioxidant properties of methotrexate and doxycycline to their treatment of cardiovascular disease","volume":"205","author":"Clemens","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111473_bb0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 family in innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.pnpbp.2025.111473_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1395771","article-title":"Schizophrenia and type 2 diabetes risk: a systematic review and meta-analysis","volume":"15","author":"Dong","year":"2024","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111473_bb0060","first-page":"47","article-title":"Association of cytokines levels, psychopathology and cognition among CR-TRS patients with metabolic syndrome","volume":"10","author":"Dong","year":"2024","journal-title":"Schizophrenia (Heidelberg, Germany)"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111473_bb0065","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/schbul\/sby008","article-title":"Brain subtyping enhances the neuroanatomical discrimination of schizophrenia","volume":"44","author":"Dwyer","year":"2018","journal-title":"Schizophr. Bull."},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111473_bb0070","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.tins.2005.06.008","article-title":"IL-18: a key player in neuroinflammation and neurodegeneration?","volume":"28","author":"Felderhoff-Mueser","year":"2005","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111473_bb0075","article-title":"Immuno-metabolic profile of patients with psychotic disorders and metabolic syndrome. Results from the FACE-SZ cohort","volume":"22","author":"Foiselle","year":"2022","journal-title":"Brain Behav. Immun. Health"},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111473_bb0080","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","article-title":"International consensus study of antipsychotic dosing","volume":"167","author":"Gardner","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111473_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2023.106386","article-title":"Association between cognitive function and IL-18 levels in schizophrenia: dependent on IL18 - 607 a\/C polymorphism","volume":"158","author":"Guan","year":"2023","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2025.111473_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2022.105721","article-title":"Interleukin-18 signaling system links to agitation in severe mental disorders","volume":"140","author":"Hjell","year":"2022","journal-title":"Psychoneuroendocrinology"},{"issue":"7121","key":"10.1016\/j.pnpbp.2025.111473_bb0095","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111473_bb0100","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.immuni.2017.08.009","article-title":"Foundations of immunometabolism and implications for metabolic health and disease","volume":"47","author":"Hotamisligil","year":"2017","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.pnpbp.2025.111473_bb0105","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/2042018818788802","article-title":"Cross-sectional correlates of increased IL-18 but reduced fetuin-a and oxytocin with adiposity and blood indices in metabolic syndrome patients with and without prediabetes","volume":"9","author":"Kasabri","year":"2018","journal-title":"Ther. Adv. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111473_bb0110","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5507\/bp.2014.060","article-title":"The common pathophysiology underlying the metabolic syndrome, schizophrenia and depression. A review","volume":"159","author":"Kucerova","year":"2015","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111473_bb0115","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jamacardio.2023.4115","article-title":"Mendelian randomization as a tool for cardiovascular research: a review","volume":"9","author":"Levin","year":"2024","journal-title":"JAMA Cardiol."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111473_bb0120","article-title":"Consensus on potential biomarkers developed for use in clinical tests for schizophrenia","volume":"35","author":"Lin","year":"2022","journal-title":"Gen. Psychiatry"},{"issue":"22","key":"10.1016\/j.pnpbp.2025.111473_bb0125","article-title":"Mitigating hemoglobin-induced nephropathy: ApoHb-hp protection of podocytes","volume":"12","author":"Lucas","year":"2024","journal-title":"Phys. Rep."},{"issue":"10","key":"10.1016\/j.pnpbp.2025.111473_bb0130","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3390\/metabo10100410","article-title":"Adipocytokines and metabolic syndrome in patients with schizophrenia","volume":"10","author":"Mednova","year":"2020","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111473_bb0135","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12974-024-03244-y","article-title":"Interleukin-2 improves insulin sensitivity through hypothalamic sympathetic activation in obese mice","volume":"21","author":"Moon","year":"2024","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111473_bb0140","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.schres.2015.03.034","article-title":"Increased cardiometabolic dysfunction in first-degree relatives of patients with psychotic disorders","volume":"165","author":"Mothi","year":"2015","journal-title":"Schizophr. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2025.111473_bb0145","first-page":"20","article-title":"Metabolic considerations in the use of antipsychotic medications: a review of recent evidence","volume":"68","author":"Newcomer","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"8 Suppl","key":"10.1016\/j.pnpbp.2025.111473_bb0150","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1902\/jop.2008.080232","article-title":"Gene-environment interactions and susceptibility to metabolic syndrome and other chronic diseases","volume":"79","author":"Ordovas","year":"2008","journal-title":"J. Periodontol."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111473_bb0155","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/13651501.2022.2106245","article-title":"Increased NLRP3 inflammasome expression in peripheral blood mononuclear cells of patients with schizophrenia: a case-control study","volume":"27","author":"Ozdamar Unal","year":"2023","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.pnpbp.2025.111473_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103418","article-title":"Deficiency of muscle-generated brain-derived neurotrophic factor causes inflammatory myopathy through reactive oxygen species-mediated necroptosis and pyroptosis","volume":"78","author":"Pang","year":"2024","journal-title":"Redox Biol."},{"issue":"20","key":"10.1016\/j.pnpbp.2025.111473_bb0165","first-page":"10875","article-title":"Tissue immunoexpression of IL-6 and IL-18 in aging men with BPH and MetS and their relationship with lipid parameters and gut microbiota-derived short chain fatty acids","volume":"15","author":"Ratajczak","year":"2023","journal-title":"Aging"},{"key":"10.1016\/j.pnpbp.2025.111473_bb0170","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2202-12-13","article-title":"Dysregulation of chemo-cytokine production in schizophrenic patients versus healthy controls","volume":"12","author":"Reale","year":"2011","journal-title":"BMC Neurosci."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111473_bb0175","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/s41380-022-01924-w","article-title":"Inflammation and cognition in severe mental illness: patterns of covariation and subgroups","volume":"28","author":"S\u00e6ther","year":"2023","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111473_bb0180","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/eip.13031","article-title":"Elevated levels of IL-18 associated with schizophrenia and first episode psychosis: a systematic review and meta-analysis","volume":"15","author":"Syed","year":"2021","journal-title":"Early Interv. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111473_bb0185","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0165-1781(00)00196-7","article-title":"Serum interleukin-18 levels are elevated in schizophrenia","volume":"96","author":"Tanaka","year":"2000","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2025.111473_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2023.110838","article-title":"Electroacupuncture ameliorates chronic unpredictable mild stress-induced depression-like behavior and cognitive impairment through suppressing oxidative stress and neuroinflammation in rats","volume":"206","author":"Tong","year":"2024","journal-title":"Brain Res. Bull."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111473_bb0195","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s41423-019-0296-z","article-title":"NLRP3 inflammasome blockade reduces adipose tissue inflammation and extracellular matrix remodeling","volume":"18","author":"Unamuno","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111473_bb0200","doi-asserted-by":"crossref","DOI":"10.1192\/j.eurpsy.2024.1761","article-title":"Trajectories of daily antipsychotic use and weight gain in people hospitalized for the first episode of psychosis","volume":"67","author":"Vochoskova","year":"2024","journal-title":"Eur. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111473_bb0205","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3109\/08039488.2012.745601","article-title":"Association between C-reactive protein and homocysteine with the subcomponents of metabolic syndrome in stable patients with bipolar disorder and schizophrenia","volume":"67","author":"Vuksan-Cusa","year":"2013","journal-title":"Nord. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111473_bb0210","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3390\/biom14091185","article-title":"\u201cWhole-body\u201d perspectives of schizophrenia and related psychotic illness: MiRNA-143 as an exemplary molecule implicated across multi-system dysfunctions","volume":"14","author":"Waddington","year":"2024","journal-title":"Biomolecules"},{"issue":"1S","key":"10.1016\/j.pnpbp.2025.111473_bb0215","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.chest.2020.03.012","article-title":"Cross-sectional studies: strengths, weaknesses, and recommendations","volume":"158","author":"Wang","year":"2020","journal-title":"Chest"},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2025.111473_bb0220","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.schres.2015.09.011","article-title":"Validation of a five-factor model of a Chinese mandarin version of the positive and negative syndrome scale (CMV-PANSS) in a sample of 813 schizophrenia patients","volume":"169","author":"Wu","year":"2015","journal-title":"Schizophr. Res."},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111473_bb0225","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jpsychires.2012.04.026","article-title":"Elevated interleukin-18 serum levels in chronic schizophrenia: association with psychopathology","volume":"46","author":"Xiu","year":"2012","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111473_bb0230","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40035-023-00381-x","article-title":"NLRP3 inflammasome in cognitive impairment and pharmacological properties of its inhibitors","volume":"12","author":"Xu","year":"2023","journal-title":"Transl. Neurodegener."},{"issue":"24","key":"10.1016\/j.pnpbp.2025.111473_bb0235","doi-asserted-by":"crossref","first-page":"17170","DOI":"10.3390\/ijms242417170","article-title":"Molecular mechanisms of IL18 in disease","volume":"24","author":"Yamanishi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111473_bb0240","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1517\/17425255.2011.532787","article-title":"Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction","volume":"7","author":"Zhang","year":"2011","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.pnpbp.2025.111473_bb0245","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.psyneuen.2016.03.002","article-title":"Serum IL-18 level, clinical symptoms and IL-18-607A\/C polymorphism among chronic patients with schizophrenia in a Chinese han population","volume":"68","author":"Zhang","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2025.111473_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116863","article-title":"The role of pyroptosis in metabolism and metabolic disease","volume":"176","author":"Zheng","year":"2024","journal-title":"Biomed. Pharmacother."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625002271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625002271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T19:28:19Z","timestamp":1765913299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584625002271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":50,"alternative-id":["S0278584625002271"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111473","relation":{},"ISSN":["0278-5846"],"issn-type":[{"type":"print","value":"0278-5846"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual role of Interleukin-18 in linking metabolic and psychiatric symptoms: Insights from machine learning in schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111473","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111473"}}